Concepedia

Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis

Betti Giusti, Anna Maria Gori, Rossella Marcucci, Claudia Saracini, Ilaria Sestini, Rita Paniccia, Piergiovanni Buonamici, David Antoniucci, Rosanna Abbate, Gian Franco Gensini

The American Journal of Cardiology · 2009 · 222 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz et al. · Circulation · 2002 · 1K citations · Full text

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

Martine Gilard, Arnaud Bertrand, Jean‐Christophe Cornily et al. · Journal of the American College of Cardiology · 2008 · 1K citations

, , +8

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

S.M. de Morais, G. Wilkinson, Joyce Blaisdell et al. · Journal of Biological Chemistry · 1994 · 952 citations · Full text

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

Jean‐Sébastien Hulot · Blood · 2006 · 925 citations · Full text

Variability in platelet responsiveness to clopidogrel among 544 individuals

Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger et al. · Journal of the American College of Cardiology · 2005 · 776 citations

, , +6